Development Generic Drugs In-Vivo Pharma Companies 
Camargo
NOVEMBER 11, 2020
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. Presumably, Antares’ long-established 90-person urology sales force can achieve pull-thru of this drug product. In October, the U.S.
World of DTC Marketing
JANUARY 31, 2021
I always have pointed instances in which pharma puts Wall Street first and patients second. Porter points out that R&D seems to have been replaced with mergers and acquisitions, but she misses the big picture by focusing solely on drug costs. In pharma R&D returns have declined to 1.8 percent—a slight decrease of 0.1
Expert insights. Personalized for you.
242 
Let's personalize your content